8Why Save the Hearing You Have

FFrom sacrifice to preservation

The old paradigm held that the trauma of insertion inevitably abolished residual hearing, so candidacy was restricted to profound losses and surgical technique was indifferent to the cochlea's survival. Two developments overturned this: short and soft electrode designs that reach low-frequency-preserving depths, and atraumatic 'soft surgery' technique that keeps the cochlear environment intact. Hearing preservation is now reported as routinely achievable in a large majority of well-selected cases—for example the Hybrid 10 trial preserved measurable hearing in 85 of 87 ears at activation. Preservation is graded on a consensus scale (complete / partial / minimal / loss) comparing pre- and postoperative residual thresholds, so outcomes can be compared across centres. The shift reframes the surgeon's job: the cochlea is now a structure to be protected, not a space to be filled.[2009][2013][2020]

TThe payoff: electric-acoustic stimulation

Preserved low-frequency hearing lets the patient combine an acoustic hearing aid (apically) with electric stimulation (the implanted base) in the same ear—electric-acoustic stimulation (EAS), also called hybrid (see Ch.13). EAS listeners consistently outperform full-electric listeners on speech-in-noise, because low-frequency acoustic hearing carries fine-structure and voicing cues the electric channels code poorly. The same acoustic low frequencies underpin better pitch perception, melody recognition and music appreciation—domains where conventional CI alone remains weak. Acoustic cues also aid talker segregation and localization, helping in the cluttered, multi-talker situations patients care most about. These benefits depend on the very thresholds the surgeon preserves, tying programming and rehabilitation directly back to the operation.[2009][2017][2020]

CFuture-proofing and the atraumatic dividend

A cochlea preserved with surviving hair cells, an intact basilar membrane and minimal fibrosis is a better substrate for emerging biological therapies—gene therapy, hair-cell regeneration, neurotrophin delivery—than a scarred, ossified one (see the Emerging Technology chapter). Even when no acoustic hearing remains usable, atraumatic technique benefits conventional full-electric recipients: less intracochlear fibrosis and neo-ossification means lower, more stable impedances, preserved spiral-ganglion neurons, and a cleaner electrode-neuron interface. Preserved neural survival is a plausible contributor to the better outcomes seen with scala-tympani, non-translocated placements. Hearing preservation therefore is not a niche goal for the hybrid patient; it is a quality marker for the whole operation. This is why the soft-surgery, electrode-design and pharmacological strategies in the chapters that follow apply to every recipient, not just EAS candidates.[2020][2008][2020]

CExpanding candidacy

Because residual low-frequency hearing can now be kept and used, candidacy has expanded to patients with substantial low-frequency acoustic hearing and a steeply sloping ('ski-slope') high-frequency loss who would once have been told they were 'too good' for an implant. These patients typically have good low-pitched hearing but poor word understanding because the high frequencies that carry consonants are gone—exactly the gap electric stimulation fills. EAS/hybrid candidacy criteria are defined partly by audiometric cut-offs (preserved low-frequency thresholds with poor aided speech scores) rather than by a uniformly profound loss. The counselling conversation changes too: the goal becomes preserving and adding to existing hearing, not replacing a dead ear (see Counselling/Consent chapter). Expanded candidacy increases the population who can benefit, but raises the stakes on atraumatic technique, since these patients have the most to lose.[2020][2009][2017]